Humonix Biosciences
Humonix Biosciences is dedicated to advancing medicine through 3D human tissue technology. They develop physiologically relevant 3D human tissue models to support testing and screening throughout the drug development pipeline. Their approach involves close collaboration with clients to design studies that meet specific needs, providing faster data compared to traditional animal studies. Their product offerings include models for retinal vascular dysfunction and glaucoma, among others, aiming to improve disease modeling and drug testing.
Industries
Nr. of Employees
small (1-50)
Products
Retinal vascular dysfunction tissue model
An in vitro biomimetic model of retinal vasculature intended for mechanistic studies and compound evaluation relevant to retinal vascular dysfunction.
Glaucoma tissue model (trabecular outflow)
In vitro tissue model representing trabecular outflow structures for evaluation of glaucoma-relevant mechanisms and interventions.
Pulmonary fibrosis tissue model (in development)
In vitro pulmonary fibrotic tissue construct under development to model fibrotic pathology for testing and discovery.
Pulmonary arterial hypertension (PAH) tissue model (in development)
In vitro tissue model under development to represent pulmonary arterial hypertension biology for preclinical testing.
Retinal vascular dysfunction tissue model
An in vitro biomimetic model of retinal vasculature intended for mechanistic studies and compound evaluation relevant to retinal vascular dysfunction.
Glaucoma tissue model (trabecular outflow)
In vitro tissue model representing trabecular outflow structures for evaluation of glaucoma-relevant mechanisms and interventions.
Pulmonary fibrosis tissue model (in development)
In vitro pulmonary fibrotic tissue construct under development to model fibrotic pathology for testing and discovery.
Pulmonary arterial hypertension (PAH) tissue model (in development)
In vitro tissue model under development to represent pulmonary arterial hypertension biology for preclinical testing.
Services
Collaborative service to design, implement, and analyze bespoke preclinical studies using 3D human tissue constructs.
Screening and efficacy assessment of compounds using engineered human tissue models to inform drug development decisions.
Collaborative service to design, implement, and analyze bespoke preclinical studies using 3D human tissue constructs.
Screening and efficacy assessment of compounds using engineered human tissue models to inform drug development decisions.
Expertise Areas
- 3D human tissue engineering
- In vitro disease modeling
- Preclinical efficacy testing and drug screening
- Ophthalmic disease models (retina and glaucoma)
Key Technologies
- 3D tissue engineering
- Biomimetic vascular tissue models
- Organotypic retinal models
- In vitro disease modeling